News
A University of Dundee spinout has announced a multi-million pound deal to develop first-in-class therapeutics that restore the body's natural disease suppression processes.
News
A University of Dundee spinout has announced a multi-million pound deal to develop first-in-class therapeutics that restore the body's natural disease suppression processes.
Press release
Outstanding scientific research at the University of Dundee has been honoured by Scotland’s national academy
Press release
Some of Scotland’s brightest business prospects are preparing for an exciting future after being crowned winners of a major Scottish competition.
News
The University of Dundee’s Drug Discovery Unit has announced a renewed partnership with Takeda, and the University of Cambridge to continue their work to discover new therapeutic treatments for dementia
Press release
Ground-breaking research into new forms of contraception have been boosted significantly with new support.
News
Parliamentarians from across the political spectrum today heard how University of Dundee research could help save millions of lives in low- and middle-income countries (LMICs)
Press release
A drug developed at the University of Dundee for a neglected tropical disease could be repurposed to treat leukaemia following Fast Track Designation by the U.S. Food and Drug Administration (FDA).
Press release
Three spinout projects from the University of Dundee with the potential to deliver significant healthcare benefits have received more than £250,000 from Scottish Enterprise to support their development.
Press release
The Universities of Dundee and Edinburgh are playing key roles in a €77.7 million pan-European consortium seeking to accelerate the development of therapies for Covid-19 and future coronaviruses.
Press release
The University of Dundee is working with partners around the world to rapidly repurpose existing drugs against Covid-19.
Press release
The University of Dundee Drug Discovery Unit is delighted to announce it has licensed assets to Corbin Therapeutics to develop possible new treatments for neuroinflammation-based disorders, including multiple sclerosis (MS).